SCHEMBL28722897

SCHEMBL28722897

Fc1ccc2ccc(N3CCCCCC3)nc2c1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHMT2 P34897 1/20 0.43
▸ MAP4K4 O95819 1/20 0.43
▸ MAOB P27338 5/20 0.40
▸ PIM1 P11309 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ HSD17B14 Q9BPX1 1/20 0.39
▸ PARP1 P09874 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29496047 1.00 SHMT2 (0.43) SHMT2MAP4K4MAOBPIM1ALDH1A1
SCHEMBL29495968 0.86 GAA (0.50) SHMT2PIM1GAASMN1; SMN2
SCHEMBL29496103 0.84 GAA (0.55) SHMT2PIM1GAASMN1; SMN2
SCHEMBL28722024 0.84 GAA (0.55) SHMT2PIM1GAASMN1; SMN2
SCHEMBL29496154 0.75 MAP3K12 (0.34) SHMT2GAA
SCHEMBL29495994 0.73 GAA (0.49) MAP4K4MAOBALDH1A1MAPTMAPK1
SCHEMBL28722001 0.73 GAA (0.49) MAP4K4MAOBALDH1A1MAPTMAPK1
SCHEMBL31195870 0.73 ALDH1A1 (0.42) MAP4K4MAOBPIM1ALDH1A1MAPT
SCHEMBL22044690 0.70 MAOB (0.41) MAP4K4MAOBPIM1ALDH1A1MAPT
SCHEMBL15834207 0.69 GAA (0.72) MAP4K4PIM1ALDH1A1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269730-A 5-heteroaryl-pyridin-2-amine compounds as neuropeptide FF receptor antagonists 多曼治疗学公司 2022-04-01 — — CN disclosed
Send feedback